Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum
- 1 April 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 29 (4) , 660-662
- https://doi.org/10.1128/aac.29.4.660
Abstract
The antifungal activity of UK 49,858, a difluorophenyl bis-triazole derivative, was evaluated in vitro against seven strains of Histoplasma capsulatum and in vivo in AKR and C57BL/6 murine models of histoplasmosis. UK 49,858 had a lower toxicity for AKR and C57BL/6 mice than amphotericin B did. The therapeutic index of UK 49,858 was 4.3 for AKR mice and 7.1 for C57BL/6; with amphotericin B it was 2 for both mouse strains. Given orally, UK 49,858 compared favorably with amphotericin B given intraperitoneally in either AKR or C57BL/6 mice infected with H. capsulatum.Keywords
This publication has 3 references indexed in Scilit:
- Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesAntimicrobial Agents and Chemotherapy, 1985
- In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl esterAntimicrobial Agents and Chemotherapy, 1985
- Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketalJournal of Medicinal Chemistry, 1983